Market Overview

Research and Markets: Global Addiction Disorders Epidemiology and Patient Flow Analysis - 2012

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tp6gzs/global_addiction) has announced the addition of the "Global Addiction Disorders Epidemiology and Patient Flow Analysis - 2012" report to their offering.

Fore Pharma announced the results of its Addiction Disorders patient population study in a new report Global Addiction Disorders Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Addiction Disorders epidemiology, Addiction Disorders diagnosed patients, and Addiction Disorders treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Addiction Disorders derived from epidemiological analysis, percentage of patients diagnosed with Addiction Disorders, and percentage of patients treated with Addiction Disorders therapy.

The study helps executives estimate Addiction Disorders market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Addiction Disorders prevalence, Addiction Disorders diagnosis rate, and Addiction Disorders treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Topics Covered:

1. Addiction Disorders: Disease Definition

2. Global Addiction Disorders Patient Flow

2A. Global Addiction Disorders Prevalence

2B. Global Addiction Disorders Diagnosed Patients

2C. Global Addiction Disorders Treated Patients

3. Addiction Disorders Patient Flow in the US

3A. Addiction Disorders Prevalence in the US

3B. Addiction Disorders Diagnosed Patients in the US

3C. Addiction Disorders Treated Patients in the US

4. Addiction Disorders Patient Flow in Europe

4A. Addiction Disorders Prevalence in Europe

4B. Addiction Disorders Diagnosed Patients in Europe

4C. Addiction Disorders Treated Patients in Europe

5. Addiction Disorders Patient Flow in Germany

5A. Addiction Disorders Prevalence in Germany

5B. Addiction Disorders Diagnosed Patients in Germany

5C. Addiction Disorders Treated Patients in Germany

6. Addiction Disorders Patient Flow in France

6A. Addiction Disorders Prevalence in France

6B. Addiction Disorders Diagnosed Patients in France

6C. Addiction Disorders Treated Patients in France

7. Addiction Disorders Patient Flow in Spain

7A. Addiction Disorders Prevalence in Spain

7B. Addiction Disorders Diagnosed Patients in Spain

7C. Addiction Disorders Treated Patients in Spain

8. Addiction Disorders Patient Flow in Italy

8A. Addiction Disorders Prevalence in Italy

8B. Addiction Disorders Diagnosed Patients in Italy

8C. Addiction Disorders Treated Patients in Italy

9. Addiction Disorders Patient Flow in UK

9A. Addiction Disorders Prevalence in UK

9B. Addiction Disorders Diagnosed Patients in UK

9C. Addiction Disorders Treated Patients in UK

10. Addiction Disorders Patient Flow in Japan

10A. Addiction Disorders Prevalence in Japan

10B. Addiction Disorders Diagnosed Patients in Japan

10C. Addiction Disorders Treated Patients in Japan

11. Appendix

12. Research Methodology

12A. Sources

For more information visit http://www.researchandmarkets.com/research/tp6gzs/global_addiction

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals




View Comments and Join the Discussion!